Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Abstract: To understand how haploinsufficiency of progranulin (PGRN) causes frontotemporal dementia (FTD), we created induced pluripotent stem cells (iPSCs) from patients carrying the GRNIVS1+5G > C mutation (FTD-iPSCs). FTD-iPSCs were fated to cortical neurons, the cells most affected in FTD. Although generation of neuroprogenitors was unaffected, their further differentiation into CTIP2-, FOXP2-, or TBR1-TUJ1 double-positive cortical neurons, but not motorneurons, was significantly decreased in FTD-neural progeny. Zinc finger nuclease-mediated introduction of GRN cDNA into the AAVS1 locus corrected defects in cortical neurogenesis, demonstrating that PGRN haploinsufficiency causes inefficient cortical neuron generation. RNA sequencing analysis confirmed reversal of the altered gene expression profile following genetic correction. We identified the Wnt signaling pathway as one of the top defective pathways in FTD- iPSC-derived neurons, which was reversed following genetic correction. Differentiation of FTD-iPSCs in the presence of a WNT inhibitor mitigated defective corticogenesis. Therefore, we demonstrate that PGRN haploinsufficiency hampers corticogenesis in vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Stem cell reports. - 4, 1 (2015) , 16-24, ISSN: 2213-6711
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
-
Raitano, Susanna
Ordovàs, Laura
De Muynck, Louis
Guo, Wenting
Espuny-Camacho, Ira
Geraerts, Martine
Khurana, Satish
Vanuytsel, Kim
Tóth, Balazs I
Voets, Thomas
Vandenberghe, Rik
Cathomen, Anton
Bosch, Ludo van den
Vanderhaeghen, Pierre
Damme, Philip van
Verfaillie, Catherine M
- Beteiligte Personen und Organisationen
- DOI
-
10.1016/j.stemcr.2014.12.001
- URN
-
urn:nbn:de:bsz:25-freidok-1227801
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raitano, Susanna
- Ordovàs, Laura
- De Muynck, Louis
- Guo, Wenting
- Espuny-Camacho, Ira
- Geraerts, Martine
- Khurana, Satish
- Vanuytsel, Kim
- Tóth, Balazs I
- Voets, Thomas
- Vandenberghe, Rik
- Cathomen, Anton
- Bosch, Ludo van den
- Vanderhaeghen, Pierre
- Damme, Philip van
- Verfaillie, Catherine M
- Centrum für Chronische Immundefizienz
- Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Natural history of Pearson syndrome
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells
Natural history of Pearson syndrome
Establishing a zinc finger nuclease platform for targeted genome editing in human cell lines, primary keratinocyte stem cells and cardiomyocytes in vivo
Entwicklung von gentechnologischen Strategien zur Überwindung der Bluthirnschranke am Modell des Morbus Gaucher Typ 2
CRISPR/Cas9 - einschneidende Revolution in der Gentechnik
Clinical genome editing to treat sickle cell disease - a brief update
Generation of safe CAR T cells to target B cell malignancies
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Gene therapy for STAT3-Associated Autosomal-Dominant Hyper-Ige-Syndrome (AD-HIES) using RNA-guided nucleases
Chimerization enables gene synthesis and lentiviral delivery of customizable TALE-based effectors
Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells